Pituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Biostatistics Core, Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Pituitary. 2018 Feb;21(1):41-49. doi: 10.1007/s11102-017-0845-3.
Remission from Cushing disease (CD) after pituitary adenoma resection may be predicted by a postoperative reduction in serum cortisol level. A 2008 consensus statement recommends assessing morning cortisol levels during the first postoperative week, and replacing glucocorticoid (GC) if cortisol nadir of < 2 or < 5 µg/dL is achieved. We sought to evaluate adherence to consensus recommendations following adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma resection at our tertiary medical center, and assess time to cortisol nadir to better define the window for assessment and intervention.
We retrospectively analyzed data extracted from in-hospital electronic medical records for CD surgeries between January 1991 and September 2015. We compared cortisol levels and collection times, ACTH measurement, and postoperative and discharge GC treatment before and after consensus statement publication in July 2008.
107 surgeries were performed in 92 patients with CD. After 2008, more surgeries had at least one cortisol value assessed (67.9% before vs. 91.3% after, p = 0.033), with median initial cortisol measurement at 14 h post-surgery. However, ACTH measurement remained unchanged (42.9% vs. 43.5%; p > 0.99). Cortisol collection during GC treatment tended to increase (32.7% vs. 57.1%; p = 0.068). Of surgeries performed without prior GC treatment, 31.7 and 55.0% had a cortisol nadir of < 2 and < 5 µg/dL, respectively, within 72 h postoperative.
Our physicians were more diligent in measuring in-hospital postoperative cortisol levels consistent with 2008 consensus recommendations. Better management of cortisol measurements and their timing is an opportunity for improvement.
术后血清皮质醇水平的降低可预测库欣病(CD)的缓解。2008 年的共识声明建议在术后第一周评估晨皮质醇水平,如果皮质醇最低点<2μg/dL 或<5μg/dL,则应补充糖皮质激素(GC)。我们旨在评估在我们的三级医疗中心进行促肾上腺皮质激素(ACTH)分泌性垂体腺瘤切除术后,对该共识建议的遵循情况,并评估皮质醇最低点出现的时间,以更好地确定评估和干预的时间窗。
我们回顾性分析了 1991 年 1 月至 2015 年 9 月期间因 CD 接受手术的住院电子病历中的数据。我们比较了 2008 年 7 月发布该共识声明前后,术后和出院时 GC 治疗的皮质醇水平和采集时间、ACTH 测量值。
共对 92 例 CD 患者的 107 例手术进行了分析。2008 年后,更多的手术至少评估了一次皮质醇值(术前为 67.9%,术后为 91.3%,p=0.033),术后中位初始皮质醇测量时间为 14 小时。然而,ACTH 测量值保持不变(42.9%比 43.5%;p>0.99)。GC 治疗期间皮质醇采集量呈上升趋势(32.7%比 57.1%;p=0.068)。在未接受 GC 治疗的手术中,术后 72 小时内分别有 31.7%和 55.0%的患者皮质醇最低点<2μg/dL 和<5μg/dL。
我们的医生更注重测量符合 2008 年共识建议的住院术后皮质醇水平。更好地管理皮质醇测量及其时间是改进的机会。